Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice | Annals of Hepatology
Frontiers | Mesenchymal Stem/Stromal Cells in Progressive Fibrogenic Involvement and Anti-Fibrosis Therapeutic Properties
Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapies | Science Translational Medicine
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction | Journal of Medicinal Chemistry
Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells | Journal of the American College of Cardiology
Anti-fibrogenic strategies and the regression of fibrosis - ScienceDirect
Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis | Nature Reviews Rheumatology
Fibroblast Heterogeneity in Wound Healing: Hurdles to Clinical Translation: Trends in Molecular Medicine
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Frontiers | Hepatic Stellate Cell-Immune Interactions in NASH
Antioxidants | Free Full-Text | Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis
α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate cells activation via induction of senescence - ScienceDirect
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology -
α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis | PLOS ONE
Origin and role of hepatic myofibroblasts in hepatocellular carcinoma | Oncotarget
Cells | Free Full-Text | Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury